The average price target for Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) has increased from $103.05 to $133, ...
Bristol Myers (BMY)’ treatment of small cell lung cancer, atigotatug plus nivolumab fixed dose combination, received FDA orphan designation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback